– USA, VA – Finch AI, a leading developer of trusted AI-enabled solutions for government and commercial enterprises, today announced the appointment of Mark Goldman to its Board of Directors effective Nov. 1.
“Mark is widely recognized for his keen eye in identifying high-potential companies and his long track record of guiding and nurturing their growth. His business partnerships and technology relationships will immediately benefit Finch AI and will enhance our success during this pivotal period of growth,” said Chairman and CEO, Steve Baldwin.
About Mark Goldman
Mark Goldman is a Managing Director at global investment bank Houlihan Lokey serving as co-head of its Financial Sponsors Coverage Group, and a member of the firm’s Management Committee. As head of the Alternative Capital Coverage group within financial sponsors, he covers private equity, hedge, pension funds, sovereign wealth funds, family offices, and large multi-asset class managers. Before joining Houlihan in 2007, he was a Director and founding member of Deutsche Bank’s Mergers & Acquisitions (M&A) Group and a director in UBS’s M&A Group.
Mark Goldman earned a B.A. in Economics from Duke University, a General Course Degree from the London School of Economics, and an MBA from Duke University’s Fuqua School of Business.
About Finch
Finch AI combines mission understanding with emerging technologies to deliver the most precise insights into massive amounts of data. Its clients include the most discerning organizations with critical missions including the U.S. Intelligence Community, the Department of Defense, civilian agencies, and commercial customers in finance and media.
SOURCE: https://finchai.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
